Lifevantage EBIT Margin 2010-2023 | LFVN
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Lifevantage (LFVN) over the last 10 years. The current EBIT profit margin for Lifevantage as of December 31, 2023 is .
| Lifevantage EBIT Margin Historical Data |
| Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
| 2023-12-31 |
$0.21B |
$0.01B |
2.37% |
| 2023-09-30 |
$0.21B |
$0.01B |
2.35% |
| 2023-06-30 |
$0.21B |
$0.01B |
2.34% |
| 2023-03-31 |
$0.21B |
$0.00B |
1.42% |
| 2022-12-31 |
$0.21B |
$0.00B |
1.45% |
| 2022-09-30 |
$0.21B |
$0.00B |
1.95% |
| 2022-06-30 |
$0.21B |
$0.01B |
3.88% |
| 2022-03-31 |
$0.21B |
$0.01B |
6.67% |
| 2021-12-31 |
$0.21B |
$0.01B |
6.60% |
| 2021-09-30 |
$0.22B |
$0.02B |
8.68% |
| 2021-06-30 |
$0.22B |
$0.02B |
7.69% |
| 2021-03-31 |
$0.23B |
$0.02B |
7.11% |
| 2020-12-31 |
$0.23B |
$0.02B |
7.42% |
| 2020-09-30 |
$0.23B |
$0.02B |
6.93% |
| 2020-06-30 |
$0.23B |
$0.02B |
6.90% |
| 2020-03-31 |
$0.23B |
$0.02B |
6.99% |
| 2019-12-31 |
$0.23B |
$0.02B |
6.55% |
| 2019-09-30 |
$0.23B |
$0.01B |
5.31% |
| 2019-06-30 |
$0.23B |
$0.01B |
4.42% |
| 2019-03-31 |
$0.22B |
$0.01B |
3.57% |
| 2018-12-31 |
$0.22B |
$0.01B |
3.65% |
| 2018-09-30 |
$0.21B |
$0.01B |
4.29% |
| 2018-06-30 |
$0.20B |
$0.01B |
4.43% |
| 2018-03-31 |
$0.20B |
$0.01B |
3.50% |
| 2017-12-31 |
$0.19B |
$0.01B |
2.58% |
| 2017-09-30 |
$0.19B |
$0.00B |
2.06% |
| 2017-06-30 |
$0.20B |
$0.01B |
2.50% |
| 2017-03-31 |
$0.20B |
$0.01B |
3.47% |
| 2016-12-31 |
$0.21B |
$0.01B |
5.16% |
| 2016-09-30 |
$0.22B |
$0.01B |
6.02% |
| 2016-06-30 |
$0.21B |
$0.01B |
6.80% |
| 2016-03-31 |
$0.20B |
$0.01B |
6.06% |
| 2015-12-31 |
$0.19B |
$0.01B |
4.81% |
| 2015-09-30 |
$0.18B |
$0.01B |
4.92% |
| 2015-06-30 |
$0.19B |
$0.01B |
7.37% |
| 2015-03-31 |
$0.20B |
$0.02B |
8.46% |
| 2014-12-31 |
$0.21B |
$0.02B |
9.48% |
| 2014-09-30 |
$0.22B |
$0.02B |
10.23% |
| 2014-06-30 |
$0.21B |
$0.02B |
8.88% |
| 2014-03-31 |
$0.21B |
$0.02B |
7.14% |
| 2013-12-31 |
$0.21B |
$0.02B |
7.32% |
| 2013-09-30 |
$0.21B |
$0.01B |
4.85% |
| 2013-06-30 |
$0.21B |
$0.01B |
5.77% |
| 2013-03-31 |
$0.20B |
$0.02B |
8.96% |
| 2012-12-31 |
$0.19B |
$0.02B |
10.70% |
| 2012-09-30 |
$0.16B |
$0.02B |
15.09% |
| 2012-06-30 |
$0.13B |
$0.02B |
15.87% |
| 2012-03-31 |
$0.10B |
$0.02B |
15.63% |
| 2011-12-31 |
$0.07B |
$0.01B |
14.29% |
| 2011-09-30 |
$0.05B |
$0.01B |
13.46% |
| 2011-06-30 |
$0.04B |
$0.00B |
10.53% |
| 2011-03-31 |
$0.03B |
$0.00B |
7.41% |
| 2010-12-31 |
$0.02B |
0 |
0.00% |
| 2010-09-30 |
$0.02B |
$-0.00B |
-26.67% |
| 2010-06-30 |
$0.01B |
$-0.01B |
-63.64% |
| 2010-03-31 |
$0.01B |
$-0.01B |
-133.33% |
| 2009-12-31 |
$0.01B |
$-0.01B |
-185.71% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.080B |
$0.213B |
|
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
|
